Personen

TOP 5 Publikationen:

1. Hoffmann AE, Allwright M, Guennewig B, Rohleder C, Jieu B, Köthe D, Dammann I, Del Castillo AA, Mueller JK, Enning F, Shepherd CE, Couttas TA, Leweke FM. Identification of fluid endocannabinoid and sphingolipid biomarkers in schizophrenia. A machine learning approach toward clinical value.Mol Psychiatry. 2026 Oct 30. [Epub ahead of print].
2. Rivolta D, Castellanos NP, Stawowsky C, Helbling S, Wibral M, Grützner C, Koethe D, Birkner K, Kranaster L, Enning F, Singer W, Leweke FM, Uhlhaas PJ. Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing.J Neurosci. 2014 34(17):5909-17.
3. Ceccarini J, De Hert M, van Winkel R, Peuskens J, Bormans G, Kranaster L, Enning F, Koethe D, Leweke FM, Van Laere K. Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia.Neuroimage. 2013 79:304-312. Epub 2013 Apr 25.
4. Severance EG, Gressitt KL, Alaedini A, Rohleder C, Enning F, Bumb JM, Müller JK, Schwarz, Prof. Ph.D E, Yolken RH, Leweke FM. IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.Brain Behav Immun. 2015 44:148-58. Epub 2014 Sep 19.
5. Kleindienst N, Steil R, Priebe K, Müller-Engelmann M, Lindauer P, Krause-Utz A, Friedmann F, Schmahl C, Enning F, Bohus M. Is dissociation predicting the efficacy of psychological therapies for PTSD? Results from a randomized controlled trial comparing Dialectical Behavior Therapy for PTSD (DBT-PTSD) and Cognitive Processing Therapy (CPT).Psychol Med. 2025 55:e59.